INDV-6001
INDV-6001-201
Phase 2 small_molecule completed
Quick answer
INDV-6001 for Moderate to Severe Opioid Use Disorder is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Moderate to Severe Opioid Use Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed